Senators to grill Moderna CEO on its four-fold price hike of COVID-19 vaccine that feds helped make

Prominent drugmakers want to more than quadruple the price of their COVID-19 vaccines when the shots transition to the commercial market later this year, sparking a showdown with congressional lawmakers who say Pfizer and Moderna benefited from taxpayer largesse and are now gouging the public to pad handsome profits.